Erectile dysfunction
123 results
1 - 100
Erectile dysfunction 
Ginseng for erectile dysfunction- Yohimbine for erectile dysfunction
- Vardenafil for erectile dysfunction
- Alprostadil for erectile dysfunction
- Psychosocial interventions for erectile dysfunction
- Penile rehabilitation for postprostatectomy erectile dysfunction
- Low‐intensity shockwave therapy for erectile dysfunction
- Phosphodiesterase inhibitors for erectile dysfunction
- Group psychotherapy for erectile dysfunction
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
- Prostaglandin E1 for treatment of erectile dysfunction: Cochrane systematic review
- Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis: Cochrane systematic review
- Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea
- Managing sexual dysfunction induced by antidepressant medication
- Care pathway for patients with ED - Image
- Algorithm for examination of patients with ED - Image
- Management of sexual dysfunction due to antipsychotic drug therapy
- Interventions for treating sexual dysfunction in patients with chronic kidney disease: Cochrane systematic review
Testosterone does not improve sildenafil effectiveness- Strategies for managing sexual dysfunction induced by antidepressant medication
- Minimally invasive vs open radical prostatectomy
- Testosterone replacement in men with sexual dysfunction
- Peripheral neuropathies: examination of the patient
- Steps of pharmacological and surgical treatment of ED - Image
- Optimal time of day to measure serum testosterone levels varies with age
- Risk of melanoma increases minimally, if at all, with the use of PDE5 inhibitors
- Tadalafil effective for benign prostatic hypertrophy
- USPSTF 2018 recommends counseling 55 to 69-year-old men on benefits and harms of prostate cancer screening (C recommendation)
- Chronic prostatitis
- PREDICT Prostate online risk score accurately predicts the prognosis for men with nonmetastatic prostate cancer
- Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)
- Male hypogonadism and hormone replacement
- Premature or delayed ejaculation
- Prostate cancer screening increases harm risk without decreasing mortality
- PSA test in prostate cancer screening
- Finasteride for benign prostatic hyperplasia
- Benign prostatic hyperplasia
- Klinefelter’s syndrome
- Pine bark (Pinus spp.) extract for treating chronic disorders
- Prostatectomy does not significantly reduce mortality in up to 20 years of follow-up
- Hair loss and balding
- Ocular adverse effects of systemic medication
- PSA screening for prostate cancer not recommended (USPSTF)
- Diabetic neuropathy
- Muscle weakness and paralysis symptom
- Radical prostatectomy versus deferred treatment for localised prostate cancer
- Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis
- Alfuzosin (alpha-agonist) not effective for chronic prostatitis-chronic pelvic pain
- Parkinson's disease
- Prostate cancer
- Adult circumcision prevents HIV transmission in sub-Saharan African men